Crack in a pill? Controlled drug delivery system? It’s priced at less than a quarter. 10-for-1 back in October, 2012. It all sounds like the second coming of Pablo Escobar’s plot to take over the world in bits and pieces. Put it all together and you get the penny stock of Crown Marketing (OTC: CWNM), Learned Hand’s Company that’s so sure of itself that it needs no Inc. or Corp. as a suffix. The time has finally come for a novel controlled-release technology that harnesses the principles of diffusion through precise mathematical formulas to be swallowed. Translation: CWNM stock is on the short list of OTC stock alerts in play.
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
CWNM Stock Chart
Market Cap: 45.62M
Last: 0.24 ▲ 0.03 (14.29%)
Dollar Volume: $29,135
Issued and Outstanding: 190,067,600
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
Decades of oral ingestion of medication and, thanks to harnessing the principles of the chaos theory and chemical potentials, a breakthrough technology in a multi-trillion dollar industry has been discovered (or fabricated). Traders looking into CWNM stock should expect to see some PR fluff prior to the open today.
Traditionally swallowed to dissolve in the stomach and gastrointestinal tract, Crown Marketing, from the acquisition of two patents and the related intellectual property from Farrington Pharmaceuticals LLC to the Company’s newly formed subsidiary, Pharmacokinetics Licensing Company BV., claims that they can make oral medications deliver compounds within a therapeutic range over a longer period of time.
Biotech breakthrough or PR fluff tool, Crown Marketing issued 122.6 million restricted shares of CWNM stock and a promissory note for $140,000 to get the two patents which must be the “Other Assets: $350″ that is on the 10-Q filed for the period ended September 30, 2012. What’s even scarier is looking at the “NOTE 5 – STOCKHOLDERS’ DEFICIENCY” portion of the Q filing:
The Company has authorized an unlimited number of shares of preferred stock, no par value, with such rights, preferences and designation and to be issued in such series as determined by the Board of Directors. No shares of preferred stock are issued and outstanding at September 30, 2012 or June 30, 2012.
The Company has authorized an unlimited number of shares of no par value common stock, of which 190,067,600 and 43,467,600 shares are outstanding at September 30, 2012 and June 30, 2012, respectively.
Holy crack pipe smokers Pablo! This may be the truest definition of a “blank check” forward stock split ever seen. Better hope the high on CWNM stock can last longer than a hit off the glass phallus.
About CWNM Stock
Crown Marketing is engaged in the wholesaling of generic pharmaceuticals to the developing world. Click here to view the SEC filings for CWNM.
Last 5 Trading Sessions:
Bottom Line: With CWNM in play during biotech month, keep a close eye if its on your list of penny stocks to buy on Humpday. While your doing to the humpty-dance when CWNM stock is green, it code get diluted in those intestinal juices of the intraday trading session real quick if they start pushing it too hard to all the OTC addicts out there.
Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter
If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)